Original Research
Frontiers in Epidemiology ·
Volume 6 - 2026 | https://doi.org/10.3389/fepid.2026.1807836
Sociodemographic determinants and prevalence of metabolic risk factors and the metabolic syndrome among women aged 20–49 in kirinyaga county, Kenya
- Umotho Kinya Mbae1*corresponding author
- Florence Kyallo1
- Dorothy Othoo1
- Zipporah Ndungu1
- Beatrice N. Kiage Mokua1,2
- Vincent Were2
- 1Jomo Kenyatta University of Agriculture and Technology, Nairobi, Kenya
- 2African Population and Health Research Centre, Nairobi, Kenya
Abstract
Globally, Noncommunicable diseases (NCDs) contribute to 75% of all deaths. The precursors to the development of NCDs include the metabolic syndrome (MetS) and key metabolic risk factors outlined by the World Health Organisation, including overweight/obesity, raised blood pressure, hyperglycemia, and hyperlipidemia. Women in Kirinyaga County in Kenya have the highest prevalence of overweight and obesity at 64.6%, and hypertension at 20%, as per the 2022 Kenyan Demographic Health survey; however, data on MetS, hyperglycemia, and hyperlipidemia in Kirinyaga is scarce. Therefore, this study aimed to determine the relationship between sociodemographic determinants and the prevalence of metabolic risk factors and the metabolic syndrome among women aged 20–49 years in Kirinyaga County, Kenya. A cross-sectional study design was employed, and multi-stage sampling was used to select 425 women aged 20–49 years in Kirinyaga County, Kenya. Data were collected on sociodemographic determinants and anthropometric and biochemical measurements. Data analysis was conducted using STATA version 17, frequencies, proportions and binary logistic regression. A total of 425 women participated in the study. The prevalence of MetS was 46.4%; 68.87% were obese or overweight; central obesity, measured by waist circumference, was 79.3%, and by waist-hip ratio, 51.06%. Diabetes was at 8.56%, elevated blood pressure at 22.6%, elevated triglycerides at 17.2%, Low HDL-C at 68.6%, and elevated cholesterol at 7.5%. The primary determinants of metabolic health were wealth and age. Increasing age (p > 0.05) elevated the odds of having all risk factors for NCDs and metabolic syndrome, except low HDL cholesterol. Women in the highest wealth quintile had increased odds of obesity (AOR = 1.83, p = 0.036), elevated triglycerides (AOR = 2.22, p = 0.035), and metabolic syndrome (AOR = 1.79, p = 0.040). However, being a student reduced the odds of metabolic syndrome (AOR = 0.24, p = 0.047). Hormonal contraceptive use, on one hand, was associated with reductions in hypertension (AOR = 0.32, p < 0.001), but was a significant risk factor for low HDL cholesterol (AOR = 2.08, p = 0.011). The study reveals a high prevalence of both metabolic syndrome and metabolic risk factors linked to noncommunicable diseases, mainly driven by ageing, multi-parity, and economic affluence. Public health interventions need to focus on wealth-associated lifestyle behaviours.
Keywords
1 Introduction
Noncommunicable diseases (NCDs) are a major public health challenge, contributing to 75% of all deaths worldwide (1), with 73% of these deaths happening in low and middle-income countries. The key metabolic risk factors for NCDs, according to the World Health Organisation, include being overweight or obese, having raised blood pressure, including hypertension, hyperglycemia, and hyperlipidemia (1). The clustering of metabolic risk factors in a single individual usually indicates the presence of the metabolic syndrome (MetS), which, according to the Joint Interim statement, is diagnosed when one has three or more of the following abnormalities: elevated waist circumference, elevated triglycerides, reduced high-density lipoprotein cholesterol, elevated blood pressure or elevated fasting glucose (2).
Globally, 2.5 billion people are overweight, with 890 million affected by obesity, 830 million people are living with diabetes, and 1.4 billion adults between 30 and 79 have hypertension, and only 320 million people have it controlled (3–5). When it comes to dyslipidemias, the global prevalence of hypertriglyceridemia is 28.85, hypercholesterolemia is 24.1%, and low HDL-C is 38.4% (6). In Africa, 18.5%% of women and 8.8% of men are obese, thirty-six per cent are hypertensive, 8.7% of the women and 8.3% of the men have diabetes, and the prevalence of dyslipidemia ranges from 5.2% to 88.9% (7, 8).
When it comes to metabolic syndrome, 1.54 billion adults globally have the metabolic syndrome, with women leading at 31% (846 million), while 25.7% (692 million) of men have MetS (9). In Africa, the prevalence of the metabolic syndrome is currently at 32.4%, with females taking the lead at a prevalence of 36.9%. In comparison, males have a prevalence of 26.7%. Within African regions, South Africa is the most affected at 33.6%, followed by West Africa at 33.1%, North Africa at 32.8%, East Africa at 30.3%, and Central Africa at 30.1% (10).
In Kenya, the prevalence of metabolic risk factors shows a clear gender disparity, where women are disproportionately affected. National demographic data highlights that forty-five per cent of women are either obese or overweight, as compared to seventeen per cent of men (11). Hypertension is at nine per cent among women, while three per cent of the men have been diagnosed with hypertension; the prevalence of elevated blood glucose is at 1% for both men and women (11). Meanwhile, 7.3% of men and 12.8% of women in Kenya have high cholesterol levels (12). In Kenya, the prevalence of the Mets in the urban population was at 25.6% (13). Amongst the 47 counties in Kenya, women in Kirinyaga County have the highest prevalence of obesity or overweight, at 64.6% of the women are either obese or overweight, and the prevalence of hypertension among women is at 20% (11).
The presence of the metabolic risk factors for NCDs has profound long-term consequences if left unaddressed. Apart from the immediate clinical burden, they are major determinants of disability adjusted life years (DALYs) and premature mortality. In 2021 alone, high body mass index (BMI) contributed to 3.7 million deaths from cancers, cardiovascular diseases, neurological disorders, diabetes, digestive diseases and chronic respiratory diseases (14). Furthermore, high blood pressure caused 11 million deaths (5), while high systolic blood pressure led to 255.5 million DALYs. Diabetes and kidney disease, as a result of diabetes, led to over two million deaths in 2021 (4), while high fasting plasma glucose led to 155.7 million Disability Adjusted Life Years (14).
Despite this clear evidence of an obesity and hypertension crisis among women in Kirinyaga County, data regarding the full spectrum of metabolic health, specifically blood glucose levels, lipid profiles and the overall magnitude of the metabolic syndrome, remains scarce. The literature suggests that these metabolic risks are driven by a complex interplay of socio-demographic and socio-economic determinants as risk factors for non-communicable diseases: age, pregnancy, parity, menopause, use of birth control pills, marital status, educational level, residential area, employment status, and household wealth index (13, 15–18).
Consequently, it is important to map out these risk factors to inform comprehensive targeted interventions. Thus, this study aimed to determine the prevalence of key metabolic risk factors and metabolic syndrome among women aged 20–49 years in Kirinyaga County, and to examine the socio-demographic determinants associated with these risks.
2 Materials and methods
2.1 Study area
The study was conducted in Kirinyaga County. The county is strategically located along the equator on the windward side of Mt. Kenya. It has a tropical climate and an equatorial rainfall pattern, making it suitable for agriculture. Agriculture is the county's main economic activity, accounting for 43.9% of its GDP. It produces some of the world's finest coffee and the most aromatic rice in East Africa. It also boasts agricultural exports, including horticulture and macadamia. The county is divided into five sub-counties: Kirinyaga East, Kirinyaga West, Mwea East, Mwea West, and Kirinyaga Central. Kirinyaga County has an estimated population of 610,411, comprising 49.4% males and 50% females. 6% females, as per the 2019 Kenya Population and Housing Census. It lists the number of females aged 20–49 years to be a total of 134,219, where Kirinyaga Central has a total of 27,181 women, Kirinyaga East has 26,605 women, Kirinyaga West has 24,417 women, Mwea East (Kirinyaga South) has 30,661 women, Mwea East (Kirinyaga North) has 23,339 women, and Mt. Kenya Forest has 15 women.
Kirinyaga County has one Public Level Five hospital, known as Kerugoya County Referral, located in Kirinyaga Central. It has three Level Four public hospitals in Kirinyaga South, Kirinyaga East, and Kirinyaga West. It has 23 public Level Three healthcare facilities and 45 public Level Two healthcare facilities. This study was conducted across two sub-counties: Kirinyaga North (Mwea West) and Kirinyaga Central.
2.2 Study design
A cross-sectional study was used to collect data on sociodemographic and metabolic risk factors associated with noncommunicable diseases, and data were collected in July 2025. The merits of the cross-sectional study design include the fact that exposure and outcome are measured simultaneously, allowing data to be collected once and then analysed.
2.3 Study population
The study population consisted of females of reproductive age (20–49 years) who were residents of Kirinyaga County for the past year (19). Females who were residents of Kirinyaga County but were expectant, or three months postpartum, were excluded, as they could affect the study estimates (15).
2.4 Sample size determination and the sampling procedure
The sample size of 423 persons was determined using the formula by Fisher et al. (74), shown below
Where n = desired sample size (if the population is more than 10,000).
n=Z2*p(1−p)e2
z = standard normal deviate at the required confidence level (Set at 1.96, corresponding to 95%).
p = population proportion estimated to have metabolic syndrome, set at 50% because it is unknown.
d = desired precision set at 0.05.
Therefore, on substitution:
n = (1.96 × 1.96 × 0.5 × 0.5) ÷ (0.05 × 0.05)
= (0.9604) ÷ (0.0025)
= 384.16
To account for attrition, a 10% non-response rate was added.
n = 384.16 + (10/100) 384.16
= 422.56 ≈ 423
Multi-stage random sampling methods were used to select the study participants. Kirinyaga County has five sub-counties.
Two of the sub-counties were randomly selected, representing 1/3 of the five sub-counties. The two sub-counties had a total of 9 wards, and 1/3 of these wards were randomly selected to participate in the study. Sampling was then conducted in community units within these wards (Supplementary File One Included).
2.5 Data collection procedures
Demographic information was collected through a structured questionnaire, administered by the researcher. It collected data on individuals, including age, marital status, gravidity and parity, family planning education, occupation, and housing and social amenities.
Physical measurements: Biochemical measurements: To avoid pricking patients twice, an expert phlebotomist drew blood from each patient once, using the antecubital vein. A drop of whole blood from the syringe was used to estimate blood glucose levels using the On-Call Plus glucometer. The remaining blood was centrifuged at approximately 3,000 rpm for 10–15 min to separate plasma from blood cells. Since the analysis could not be performed at the collection point. The plasma fraction was transported to Kerugoya County Referral Hospital, where it was used to determine the lipid profile.
- Weight was measured using a calibrated SECA weighing scale, and two measurements were taken for each person. Weight was measured to the nearest 0.1 kg. Participants were asked to remove heavy outer garments, shoes, and accessories. They then stood still on the centre platform, with their weight evenly distributed on both feet and their arms hanging loosely at their sides.
- Height was measured using an adult stadiometer, and two measures were taken for each person. It was measured to the nearest 0.1 cm using a calibrated stadiometer after participants removed their shoes and headgear. Participants stood upright, with their heels, buttocks, and scapulae in contact with the vertical board. The movable headpiece was then lowered to gently compress the hair and rest firmly on the highest point of the head.
- Waist and hip circumferences were measured with a SECA non-stretchable waist tape to the nearest 0.1 cm, with two measurements taken with each tape. Waist circumference measurement was taken at the midpoint between the inferior margin of the last palpable rib and the top of the iliac crest. The tape was kept horizontal to the floor, and the reading was recorded at the end of a normal expiration without compressing the skin. Hip circumference measurement was taken at the level of the maximum posterior extension of the buttocks.
- Blood pressure was measured using an OMRON Automatic blood pressure monitor, with an appropriately sized cuff based on the participant's upper arm circumference. Prior to the measurements, participants rested for at least 5 min in a seated position. The measurement was conducted on the left arm while the participant was seated with back support, with the arm supported on a table at heart level. Three consecutive readings were taken.
2.6 Pre-testing
The tools were pre-tested in Inoi ward with 42 participants, representing 10% of the total sample, and the results helped refine and standardise the questionnaire. Statistical reliability was determined using Cronbach's alpha, which was 70% and thus considered satisfactory.
2.7 Data management and analysis
Data collection was done through the Commcare app. The data were then downloaded and exported to STATA version 17for data analysis. The data was analysed using descriptive and inferential statistics. Frequencies and proportions were used to analyse sociodemographic data and the prevalence of metabolic risk factors for noncommunicable diseases and the metabolic syndrome. Binary logistic regression was employed to determine the relationships between sociodemographic factors and metabolic risk factors for noncommunicable diseases, as well as between sociodemographic factors and metabolic syndrome.Statistical significance was determined at the 95% confidence level, with a p-value threshold of <0.05.
The wealth quintiles were computed using the Multiple Correspondence Analysis (20). It created a composite socio-economic status (SES) index based on household assets and characteristics. The following households’ assets and characteristics were used to calculate it: dwelling type, housing rental status, toilet facility, and access to electricity, water source, and cooking energy used by the household. The wealth quintiles were then divided into three categories: low, middle, and high.
In the study, metabolic risk factors and the metabolic syndrome were defined as follows: overweight was defined as a BMI above 25 kg/m2, and obesity was defined as a BMI greater than or equal to 30 kg/m2 (21). Abdominal obesity was defined as either a waist circumference of 80 cm (20) or greater or a waist-to-hip ratio greater than 0.85 (22). Pre-diabetes was defined as fasting blood glucose 5.6–6.9 mmol/L, while diabetes was defined as fasting blood glucose > 6.9 mmol/L (23). Elevated blood pressure was defined as an average of three readings, and women with systolic BP equal to or above 130 mmHg or diastolic BP equal to or above 85 mmHg were categorised as hypertensive (2). Dyslipidemia was defined by an abnormality in any of the following three lipid parameters. The parameters included triglyceride levels greater than or equal to 1.7 mmol/L, HDL-C levels equal to or lower than 1.3 mmol/L, and cholesterol levels above 5 mmol/L (2). Metabolic syndrome was defined according to the 2009 Joint Interim Statement (2), where presence of three or more of the following risk factors indicated the presence of MetS; a waist circumference greater than or equal to 80 cm; fasting blood glucose that was greater than or equal to 5.6 mmol/L; elevated blood pressure, where the systolic blood pressure was greater than or equal to 130mmhg and the diastolic blood pressure was greater than or equal to 85mmhg; High-density lipoprotein below 1.3 mmol/L and triglycerides greater than or equal to 1.7 mmol.
2.8 Ethical considerations
The study strictly adhered to the Helsinki declarations. The JKUAT Institutional Scientific and Ethics Review Committee (ISEREC) reviewed the study and granted ethical approval (License no.). JKU/ISERC/02316/1727. Ethical permission was also granted by the National Commission for Science, Technology, and Innovation (NACOSTI), Kenya license no: NACOSTI/P/25/4174059. Each Study participant confirmed their willingness to participate by signing an informed consent form.
3 Results
A 100.5% response rate was achieved, with 425 participants from Kirinyaga County participating in the research study.
Table 1 details the sociodemographic and reproductive characteristics of the study participants. The majority of the women were between 30 and 49 years old. The age groups with the highest numbers of participants were 40–49 (39.1%) and 30–39 (37.9%). Most women came from households with fewer than 4 persons below 18 years (96.24%) and fewer than 4 persons above 18 years (87.06%). Regarding marital status (71.3%) were currently married. Regarding reproductive history, the vast majority of women reported a parity of 4 or fewer (95.5%) and a gravidity of 4 or fewer (94.4%). Contraceptive use was high, where 27.53% did not use it, and 72.46 of the women used it; hormonal contraception was used by 59.8% of the participants.
Table 1. Socio-demographic characteristics of women aged 20–49 years in kirinyaga county, Kenya (N = 425). A 100.5% response rate was achieved with 425 participants from Kirinyaga participating in the research study.
| Variable | Percentages (%) | Frequency (n) |
|---|---|---|
| Age (years) | ||
| 20–29 | 23.06 | 98 |
| 30–39 | 37.88 | 161 |
| 40–49 | 39.06 | 166 |
| Household members under 18 | ||
| Below 4 persons | 96.24 | 409 |
| 4 persons and above | 3.76 | 16 |
| Household members over 18 | ||
| Below 4 persons | 87.06 | 370 |
| 4 persons and above | 12.94 | 55 |
| Marital status | ||
| Never married | 10.82 | 46 |
| Currently married | 71.29 | 303 |
| Separated | 12.24 | 52 |
| Divorced | 2.12 | 9 |
| Widowed | 2.82 | 12 |
| Cohabitation | 0.71 | 3 |
| Gravidity | ||
| ≤4 pregnancies | 94.35 | 401 |
| >4 pregnancies | 5.65 | 24 |
| Parity | ||
| ≤4 births | 95.53 | 406 |
| >4 births | 4.47 | 19 |
| Family planning use (FP use) | ||
| None | 27.53 | 117 |
| Non-hormonal | 2.35 | 10 |
| Hormonal | 59.76 | 254 |
| Intrauterine Devices | 10.35 | 44 |
Categorical variables are reported as frequency (n) and percentage (%).
Table 2 summarises the socioeconomic characteristics of the study participants (N = 425). The majority of participants (86.0%) had completed at least secondary education, with 41.2% holding a college, university, or postgraduate degree. Regarding employment, the largest proportion of participants were self-employed (39.8%) or working in the non-government sector (35.5%). A significant segment of the study population consisted of students (18.6%). Economically, participants were distributed across the three wealth quintiles: Low (33.4%), Middle (33.7%), and High (32.9%). The reported individual earnings revealed that 26.35% of the women earned below KES 3,000, 27.53% earned between KES 3,000–7,000, 30.36% earned between KES 7,000–15,000, and 15.76% earned above KES 15,000.
Table 2. Social economic characteristics of women aged 20–49 years in kirinyaga county (N = 425).
| Variable | Percentages (%) | frequency (n) |
|---|---|---|
| Highest education | ||
| No formal schooling | 0.94 | 3 |
| Primary completed | 13.18 | 56 |
| Secondary completed | 30.82 | 131 |
| High school completed | 13.88 | 59 |
| College/University completed | 26.82 | 114 |
| Postgraduate degree | 14.35 | 61 |
| Employment | ||
| Government employee | 3.29 | 14 |
| Non-government employee | 35.53 | 151 |
| Self-employed | 39.76 | 169 |
| Student | 18.59 | 79 |
| Informal Employment | 2.82 | 12 |
| Wealth Quintile | ||
| Low | 33.41 | 142 |
| Middle | 33.65 | 143 |
| High | 32.94 | 140 |
| Monthly income (KES) | ||
| Below 3,000 | 26.35 | 112 |
| 3,000–7,000 | 27.53 | 117 |
| 7,000–15,000 | 30.36 | 129 |
| Above 15,000 | 15.76 | 67 |
KES, kenyan shilling. Categorical variables are presented as frequency (n) and percentage (%).
Table 3 presents the prevalence of the metabolic risk factors. The results show that 68.87% of the women in Kirinyaga County were either obese or overweight. The results show that the prevalence of abdominal obesity, as measured by waist circumference, was 79.3% and, when categorised by waist-to-hip ratio, 51.06%. The prevalence of abdominal obesity was 51.06%. Glycemic indicators among fasting participants (n = 362) show that the prevalence of pre-diabetes in Kirinyaga County was 55.25%, while the prevalence of diabetes was 8.56%. The cardiovascular markers indicate that the prevalence of elevated blood pressure among women aged 20–49 years in Kirinyaga County was 22.6%. The results show that 17.2% of the women had elevated triglycerides, 68.6% had low high-density lipoprotein levels, and 7.5% had elevated cholesterol levels.
Table 3. The prevalence of the metabolic risk factors for non-communicable diseases among women aged 20–49 in kirinyaga county, Kenya.
| Indicator | Frequency | Percentage |
|---|---|---|
| BMI Category n = 425 | ||
| Underweight (>18.5 kg/m2) | 14 | 3.30 |
| Normal (18.5 kg/m2–24.9 kg/m2) | 118 | 27.83 |
| Overweight (25 kg/m2–29.9 kg/m2) | 124 | 29.25 |
| Obese (≥ 30 kg/m2) | 168 | 39.62 |
| Waist Circumference n = 425 | ||
| Normal (<80 cm) | 88 | 20.7 |
| Abdominal obesity (≥ 80 cm) | 337 | 79.3 |
| Waist-Hip Ratio | ||
| Normal (≤ 0.85) | 208 | 48.94 |
| Abdominal obesity (> 0.85) | 217 | 51.06 |
| Blood Glucose Levels n = 362a | ||
| Normal (<5.6 mmol/L) | 131 | 36.19 |
| Pre-diabetes (≥5.6 mmol/L & ≤ 6.9 mmols) | 200 | 55.25 |
| Diabetic (> 6.9 mmol/L) | 31 | 8.56 |
| Blood Pressure n = 425 | ||
| Normal BP (≤ 130/85) | 329 | 77.40 |
| High BP (≥130/85) | 96 | 22.60 |
| Dyslipidemia n = 425 | ||
| Triglycerides | ||
| Normal (<1.7 mmol/L) | 352 | 82.80 |
| Elevated (≥1.7 mmol/L) | 73 | 17.20 |
| HDL cholesterol | ||
| Normal (≥1.3 mmol/L) | 124 | 31.40 |
| Low (<1.3 mmol/L) | 271 | 68.60 |
| Cholesterol | ||
| Normal (≤5 mmol/L) | 393 | 92.50 |
| Elevated (>5 mmol/L) | 32 | 7.50 |
Analysis restricted to participants who fasted (n = 362).
BMI, body mass index.
HDL, high density lipoprotein.
BP, blood pressure.
Table 4 shows that the prevalence of the metabolic syndrome in Kirinyaga County was 46.4% (n = 197). This indicates that nearly half of the women aged 20–49 years in Kirinyaga County presented with a clustering of at least three cardiovascular risk factors. The remaining 53.6% (n = 228) had two or fewer risk factors and were classified as not having the syndrome.
Table 4. Prevalence of the metabolic syndrome among women aged 20–49 in kirinyaga county (N = 425).
| Metabolic Syndrome Status | N | % |
|---|---|---|
| No Metabolic Syndrome (< 3 risk factors) | 228 | 53.6 |
| Metabolic Syndrome (≥ 3 risk factors) | 197 | 46.4 |
| Total | 425 | 100 |
Metabolic syndrome was defined as the presence of three or more of the following risk factors.
A waist circumference greater than or equal to 80 cm.
Fasting blood glucose that was greater than or equal to 5.6 mmol/L.
Elevated blood pressure, where the systolic blood pressure was greater than or equal to 130mmhg and the diastolic blood pressure was greater than or equal to 85mmhg.
High-density lipoprotein below 1.3 mmol/L and.
Triglycerides greater than or equal to 1.7 mmol.
Table 5 presents the factors associated with obesity (BMI ≥ 25 kg/m2). The results show that increasing age was significantly associated with higher odds of obesity, at a crude OR of 1.04 (95% CI: 1.01 −1.07, p = 0.003), and an adjusted OR of 1.04 (95% CI: 1.00–1.09, p = 0.026). Parity was also associated with a higher odds of being obese, with a crude OR of 1.21 (95% CI: 1.02–1.44, p = 0.028). Women who were also separated had higher odds of being obese, this was at Crude OR of 2.56 (95% CI: 1.07–6.12, p = 0.034). Regarding economic status, women who were informally employed also had lower odds of obesity, with a crude OR of 0.09 (95% CI: 0.01–0.56, p = 0.01). Women in the high and middle income wealth quintiles were at higher odds of being obese, for women in the middle income wealth quintiles, this was at a Crude OR of 1.84 (95% CI: 1.12–3.03 p = 0.016) and at an Adjusted OR of 1.84 (95% CI: 1.08–3.13 p = 0.025) and for women in the high income wealth quintiles at a Crude OR 2.07 (95%CI: 1.25–3.44 and p = 0.005) at an Adjusted OR 2.43 (95% CI: 1.33–4.47 p = 0.004).
Table 5. Determinants of obesity (BMI ≥ 25 kg/m2) among women aged 20–49 in kirinyaga county, Kenya (N = 425).
| Variable | Crude OR (95% CI) | p-value | AOR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 1.04 (1.01–1.07) | 0.003* | 1.04 (1.00–1.09) | 0.026* |
| Gravidity | 1.12 (0.96–1.32) | 0.157 | 0.74 (0.49–1.12) | 0.157 |
| Parity | 1.21 (1.02–1.44) | 0.028* | 1.37 (0.86–2.17) | 0.189 |
| Years of schooling | 0.98 (0.92–1.06) | 0.667 | 1.08 (0.90–1.29) | 0.409 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married | 1.74 (0.92–3.27) | 0.087 | 0.95 (0.41–2.21) | 0.901 |
| Separated | 2.56 (1.07–6.12) | 0.034* | 1.34 (0.48–3.74) | 0.576 |
| Divorced | 2.69 (0.50–14.39) | 0.247 | 1.54 (0.25–9.56) | 0.643 |
| Widowed | 1.54 (0.41–5.84) | 0.527 | 0.66 (0.15–2.93) | 0.586 |
| Cohabitating | 1.54 (0.13–18.19) | 0.733 | 0.59 (0.04–8.99) | 0.701 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 1.15 (0.72–1.83) | 0.554 | 1.22 (0.64–3.25) | 0.496 |
| Non-hormonal | 4.68 (0.57–38.2) | 0.150 | 2.78 (0.32–24.24) | 0.355 |
| Intra-Uterine Devices | 1.39 (0.66–2.98) | 0.404 | 1.20 (0.52–2.75) | 0.668 |
| Highest education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 1.53 (0.80–2.93) | 0.201 | 1.27 (0.57–2.82) | 0.564 |
| Secondary incomplete | 2.05 (0.91–4.60) | 0.082 | 1.95 (0.58–6.53) | 0.280 |
| Secondary completed | 1.16 (0.60–2.23) | 0.66 | 0.85 (0.22–3.24) | 0.815 |
| College/University completed | 0.96 (0.46–2.00) | 0.906 | 0.55 (0.10–2.91) | 0.482 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 0.76 (0.20–2.85) | 0.681 | 0.74 (0.18–3.16) | 0.704 |
| Self-employed | 0.63 (0.17–2.36) | 0.494 | 0.89 (0.20–3.86) | 0.880 |
| Student | 0.47 (0.12–1.82) | 0.275 | 0.52 (0.11–2.34) | 0.395 |
| Informal employment | 0.09 (0.01–0.56) | 0.01* | 0.19 (0.03–1.40) | 0.104 |
| Average income | 1.00 (1.00–1.00) | 0.19 | 1.00 (1.00–1.00) | 0.632 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 1.84 (1.12–3.03) | 0.016* | 1.84 (1.08–3.13) | 0.025* |
| High | 2.07 (1.25–3.44) | 0.005* | 2.43 (1.33–4.47) | 0.004* |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 6 details the factors associated with abdominal obesity (waist circumference ≥ 80 cm). The results of the study show that in the bivariate analysis increases in age, gravidity, and parity were associated with greater odds of developing of abdominal obesity, at a Crude ORs of 1.03 (95% CI: 1.00–1.05 p = 0.022), 1.29 (95% CI: 1.10–1.50 p = 0.001), and 1.38 (95% CI: 1.17–1.63 p = 0), respectively. While an increase in years of schooling, with a crude OR of 0.94 (95% CI: 0.88–1.00, p = 0.06), reduced the odds of developing abdominal obesity. Women who also used intra-uterine methods of family planning had increased odds of having abdominal obesity at a Crude OR of 2.18 (95% CI: 1.06–4.48, p = 0.034). However, after adjusting for potential confounders (AOR), the only variable that remained a significant predictor of abdominal obesity in the multivariate model was wealth, with women in the high wealth quintiles having nearly double the odds of abdominal obesity compared to those in the low wealth quintiles at an adjusted OR 1.83 (95% CI: 1.04–3.23, p = 0.036).
Table 6. Determinants of abdominal obesity (waist circumference ≥80 cm) among women aged 20–49 in kirinyaga county, Kenya (N = 425).
| Variable | Crude OR (95% CI) | p-value | AOR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 1.03 (1.00–1.05) | 0.022* | 1.01 (0.97–1.04) | 0.704 |
| Gravidity | 1.29 (1.10–1.50) | 0.001* | 0.90 (0.61–1.33) | 0.554 |
| Parity | 1.38 (1.17–1.63) | 0* | 1.49 (0.96–2.31) | 0.076 |
| Years of schooling | 0.94 (0.88–1.00) | 0.06* | 1.15 (0.97–1.37) | 0.106 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married | 1.57 (0.84–2.94) | 0.16 | 0.82 (0.36–1.83) | 0.640 |
| Separated | 1.32 (0.59–2.93) | 0.501 | 0.78 (0.31–2.01) | 0.614 |
| Divorced | 2.84 (0.63–12.80) | 0.174 | 1.81 (0.35–9.37) | 0.482 |
| Widowed | 1.99 (0.55–7.22) | 0.296 | 0.74 (0.18–3.08) | 0.683 |
| Cohabitating | 0.71 (0.06–8.41) | 0.786 | 0.30 (0.02–4.66) | 0.391 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 1.18 (0.76–1.83) | 0.455 | 1.02 (0.60–1.71) | 0.392 |
| Non-hormonal | 0.48 (0.12–1.96) | 0.309 | 0.27 (0.06–1.21) | 0.088 |
| Intra-Uterine Devices | 2.18 (1.06–4.48) | 0.034* | 1.71 (0.78–3.74) | 0.179 |
| Highest education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 1.33 (0.72–2.47) | 0.358 | 1.09 (0.52–2.30) | 0.819 |
| Secondary incomplete | 1.82 (0.87–3.82) | 0.111 | 1.27 (0.42–3.87) | 0.671 |
| Secondary completed | 0.61 (0.32–1.15) | 0.124 | 0.33 (0.09–1.16) | 0.085 |
| College/University completed | 0.65 (0.32–1.33) | 0.240 | 0.28 (0.06–1.38) | 0.118 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 0.67 (0.22–2.01) | 0.471 | 0.55 (0.16–1.86) | 0.335 |
| Self-employed | 0.88 (0.29–2.63) | 0.812 | 0.80 (0.23–2.86) | 0.737 |
| Student | 0.94 (0.30–2.97) | 0.92 | 0.73 (0.20–2.73) | 0.645 |
| Informal employment | 0.25 (0.05–1.34) | 0.106 | 0.36 (0.06–2.24) | 0.271 |
| Average income | 1.00 (1.00–1.00) | 0.69 | 1.00 (1.00–1.00) | 0.781 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 1.17 (0.73–1.86) | 0.515 | 1.35 (0.82–2.23) | 0.244 |
| High | 1.26 (0.79–2.00) | 0.34 | 1.83 (1.04–3.23) | 0.036* |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 7 examines the determinants of elevated blood pressure (BP > 130/85 mmHg). The results of this study revealed that increasing age increased the odds of becoming hypertensive, with a Crude OR of 1.10 (95% CI: 1.06 –1.14, p < 0.001) and an Adjusted OR of 1.09 (95% CI: 1.05–1.14, p < 0.001). Gravidity and parity also increased the odds of developing hypertension, with Crude ORs of 1.28 (95% CI: 1.08–1.53, p = 0.005) and 1.32 (95% CI: 1.09–1.59, p = 0.004), respectively. On the other hand, the years of schooling reduced the odds of developing hypertension, with a Crude OR of 0.84 (95% CI: 0.77–0.91, p < 0.001). Persons with secondary and tertiary education had lower odds of becoming hypertensive, with Crude ORs of 0.58 (95% CI: 0.35–0.94, p = 0.026) and 0.21 (95% CI: 0.08–0.55, p = 0.002), respectively. When it came to marital status, women who were in a union had higher odds of developing hypertension, this was at a Crude OR 3.33 (95% CI: 1.16–9.61, p = 0.026). Regarding family planning, women who used hormonal methods had lower odds of developing hypertension, with a Crude OR of 0.34 (95% CI: 0.20–0.56, p < 0.001) and an adjusted OR of 0.32 (95% CI: 0.18–0.59, p < 0.001).
Table 7. Determinants of elevated blood pressure (BP > 130/85 mmHg) among women aged 20–49 in kirinyaga county, Kenya (N-425).
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 1.10 (1.06–1.14) | <0.001* | 1.09 (1.05–1.14) | <0.001* |
| Gravidity | 1.28 (1.08–1.53) | 0.005* | 1.03 (0.66–1.61) | 0.884 |
| Parity | 1.32 (1.09–1.59) | 0.004* | 0.91 (0.56–1.48) | 0.715 |
| Years of schooling | 0.84 (0.77–0.91) | <0.001* | 0.86 (0.73–1.02) | 0.078 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married/Cohabiting | 3.33 (1.16–9.61) | 0.026* | 1.53 (0.60–7.82) | 0.241 |
| Separated/Divorced/Widowed | 3.15 (0.94–10.58) | 0.063 | 1.31 (0.34–5.06) | 0.696 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 0.34 (0.20–0.56) | <0.001* | 0.32 (0.18–0.59) | <0.001* |
| Non-hormonal | 0.79 (0.19–3.24) | 0.748 | 0.49 (0.11–2.26) | 0.300 |
| Intra-Uterine Devices | 0.78 (0.37–1.65) | 0.511 | 0.54 (0.23–1.24) | 0.147 |
| Education | ||||
| Primary level | Reference | – | Reference | – |
| Secondary level | 0.58 (0.35–0.94) | 0.026* | 1.53 (0.64–3.65) | 0.335 |
| College/University | 0.21 (0.08–0.55) | 0.002* | 0.61 (0.14–2.73) | 0.519 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 1.07 (0.28–4.04) | 0.926 | 0.54 (0.12–2.44) | 0.417 |
| Self-employed | 1.17 (0.31–4.41) | 0.812 | 0.57 (0.12–2.63) | 0.468 |
| Student | 1.01 (0.25–4.02) | 0.994 | 0.50 (0.10–2.47) | 0.399 |
| Informal employment | 0.33 (0.03–3.72) | 0.372 | 0.73 (0.05–10.30) | 0.813 |
| Average income | 1.00 (1.00–1.00) | 0.418 | 1.00 (1.00–1.00) | 0.921 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 1.11 (0.64–1.93) | 0.699 | 1.35 (0.73–2.50) | 0.346 |
| High | 0.90 (0.51–1.58) | 0.71 | 1.58 (0.82–3.22) | 0.203 |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 8 shows the relationship between elevated fasting blood glucose (≥ 5.6 mmol/L) and socio-demographic factors. Increasing age was associated with higher odds of having elevated blood glucose, with a crude OR of 1.05 (95% CI: 1.03–1.08, p < 0.001). Regarding schooling, individuals who had not completed secondary education and those who had completed it had lower odds of having elevated blood glucose, with crude ORs of 0.32 (95% CI: 0.15–0.70, p = 0.004) and 0.49 (95% CI: 0.25–0.99, p = 0.046), respectively. Regarding employment, students had lower odds of developing elevated fasting blood glucose levels, with a crude OR of 0.15 (95% CI: 0.03–0.74, p = 0.019). Women who used hormonal family planning also had a lower odds of elevated blood glucose, with a crude OR of 0.41 (0.25–0.66, p < 0.001) and an adjusted OR of 0.47 (0.27–0.82, p = 0.009).
Table 8. Determinants of elevated fasting blood glucose among women aged 20–49 in kirinyaga county, Kenya (N = 362).
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 1.05 (1.03–1.08) | <0.001* | 1.03 (0.99–1.07) | 0.125 |
| Gravidity | 1.13 (0.97–1.32) | 0.121 | 0.82 (0.55–1.22) | 0.328 |
| Parity | 1.17 (0.99–1.38) | 0.065 | 1.29 (0.83–2.01) | 0.263 |
| Years of schooling | 0.95 (0.89–1.02) | 0.157 | 1.01 (0.84–1.21) | 0.893 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married/Cohabiting | 1.02 (0.54–1.93) | 0.941 | 1.11 (0.48–2.55) | 0.807 |
| Separated/Divorced/Widowed | 1.96 (0.89–4.35) | 0.097 | 1.37 (0.53–3.56) | 0.513 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 0.41 (0.25–0.66) | <0.001* | 0.47 (0.27–0.82) | 0.009* |
| Non-hormonal | 2.83 (0.34–23.34) | 0.333 | 2.15 (0.25–18.81) | 0.489 |
| Intra-Uterine Devices | 0.67 (0.341–1.45) | 0.311 | 0.58 (0.26–1.33) | 0.200 |
| Education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 0.68 (0.34–1.36) | 0.276 | 0.73 (0.32–1.67) | 0.461 |
| Secondary incomplete | 0.32 (0.15–0.70) | 0.004* | 0.48 (0.15–1.54) | 0.218 |
| Secondary complete | 0.49 (0.25–0.99) | 0.046* | 0.64 (0.17–2.44) | 0.519 |
| College/University | 0.68 (0.31–1.51) | 0.346 | 0.78 (0.15–4.19) | 0.777 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 0.32 (0.07–1.47) | 0.143 | 0.36 (0.07–1.83) | 0.217 |
| Self-employed | 0.36 (0.08–1.69) | 0.197 | 0.41 (0.08–2.15) | 0.291 |
| Student | 0.15 (0.03–0.74) | 0.019* | 0.20 (0.04–1.07) | 0.060 |
| Informal employment | 0.17 (0.03–1.09) | 0.061 | 0.25 (0.03–1.91) | 0.182 |
| Average income | 1.00 (1.00–1.00) | 0.986 | 1.00 (1.00–1.00) | 0.575 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 0.64 (0.40–1.04) | 0.073 | 0.65 (0.39–1.10) | 0.112 |
| High | 0.86 (0.52–1.41) | 0.556 | 1.14 (0.64–2.03) | 0.665 |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 9 presents the determinants of low HDL cholesterol levels (<1.3 mmol/L). Increasing age appeared protective, with a 3% reduction in the odds of low HDL per year of age, yielding a crude OR of 0.97 (0.94–0.99; p = 0.012). It is also interesting to note that women who were separated or divorced were less likely to have low HDL. For separated women, this was associated with a crude OR of 0.26 (95% CI: 0.10–0.66, p = 0.004) and an adjusted OR of 0.19 (95% CI: 0.06–0.61, p = 0.005). For women who were divorced, the crude OR was 0.16 (95% CI: 0.03–0.74) and the adjusted OR was 0.12 (95% CI: 0.02–0.72). Conversely, the use of family planning methods increased the risk of having low high-density lipoprotein levels. For women using hormonal methods, this was at a crude OR of 2.25 (95% CI: 1.37–6.78 p = 0.001) and at an Adjusted OR of 2.08 (95% CI: 1.18–3.65 p = 0.011), while for women using the intra-uterine devices, this was at a Crude OR of 2.75 (95%CI: 1.19–6.36 p = 0.018) and an Adjusted OR of 2.60 (95% CI: 1.33–6.45 p = 0.039).
Table 9. Determinants of Low HDL-cholesterol (<1.3 mmol/L) among women aged 20–49 in kirinyaga county (N = 425).
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 0.97 (0.94–0.99) | 0.012* | 1.00 (0.96–1.04) | 0.955 |
| Gravidity | 0.90 (0.77–1.06) | 0.214 | 1.08 (0.68–1.72) | 0.737 |
| Parity | 0.88 (0.74–1.05) | 0.147 | 0.84 (0.51–1.39) | 0.502 |
| Years of schooling | 1.04 (0.97–1.12) | 0.316 | 0.95 (0.78–1.16) | 0.642 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married | 0.85 (0.40–1.81) | 0.670 | 0.53 (0.19–1.48) | 0.225 |
| Separated | 0.26 (0.10–0.66) | 0.004* | 0.19 (0.06–0.61) | 0.005* |
| Divorced | 0.16 (0.03–0.74) | 0.019* | 0.12 (0.02–0.72) | 0.020* |
| Widowed | 0.25 (0.06–1.11) | 0.069 | 0.22 (0.04–1.21) | 0.082 |
| Cohabitating | 0.63 (0.05–7.64) | 0.713 | 0.22 (0.01–3.22) | 0.268 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 2.25 (1.37–6.78) | 0.001* | 2.08 (1.18–3.65) | 0.011* |
| Non-hormonal | 1.92 (0.47–7.85) | 0.362 | 2.78 (0.62–12.52) | 0.183 |
| Intra-Uterine Devices | 2.75 (1.19–6.36) | 0.018* | 2.60 (1.33–6.45) | 0.039* |
| Education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 0.55 (0.28–1.09) | 0.085 | 0.52 (0.22–1.23) | 0.136 |
| Secondary incomplete | 1.67 (0.70–4.02) | 0.250 | 1.71 (0.46–6.38) | 0.425 |
| Secondary complete | 1.19 (0.57–2.45) | 0.646 | 1.37 (0.31–5.95) | 0.676 |
| College/University | 0.74 (0.33–1.65) | 0.457 | 0.75 (0.09–3.64) | 0.759 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 1.01 (0.32–3.18) | 0.988 | 1.11 (0.31–3.96) | 0.871 |
| Self-employed | 1.30 (0.41–4.09) | 0.653 | 1.71 (0.45–6.46) | 0.429 |
| Student | 1.64 (0.49–5.50) | 0.425 | 1.51 (0.38–6.03) | 0.556 |
| Other employment | 0.97 (0.19–5.03) | 0.973 | 0.58 (0.09–3.64) | 0.558 |
| Average income | 1.00 (1.00–1.00) | 0.861 | 1.00 (1.00–1.00) | 0.950 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 1.06 (0.63–1.76) | 0.830 | 1.07 (0.61–1.87) | 0.816 |
| High | 1.43 (0.85–2.43) | 0.180 | 1.53 (0.81–2.89) | 0.185 |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 10 presents the determinants of elevated total cholesterol (>5.0 mmol/L). The results show that increasing age, reduced the odds of having elevated cholesterol level at a Crude OR of 0.97 and at (95% CI: 0.94–0.99 p = 0.012) but the odds increased at an Adjusted OR 1.07 (95% CI: 1.01–1.15 p = 0.029), while women who were previously in a union, had reduced odds of having elevated cholesterol, this was at a Crude OR of 0.26 (95% CI: 0.10–0.66 p = 0.004).
Table 10. Determinants of elevated total cholesterol (>5.0 mmol/L) among women aged 20–49 in kirinyaga county, Kenya (N = 425).
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 0.97 (0.94–0.99) | 0.012* | 1.07 (1.01–1.15) | 0.029* |
| Gravidity | 0.90 (0.77–1.06) | 0.214 | 0.95 (0.44–2.07) | 0.904 |
| Parity | 0.88 (0.74–1.05) | 0.147 | 0.75 (0.33–1.70) | 0.496 |
| Years of schooling | 1.04 (0.97–1.12) | 0.316 | 0.93 (0.69–1.25) | 0.647 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married/Cohabiting | 0.85 (0.40–1.81) | 0.67 | 6.66 (0.63–70.40) | 0.115 |
| Separated/ Divorced/ Widowed | 0.26 (0.10–0.66) | 0.004* | 5.92 (0.52 –66.75) | 0.151 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 0.47 (0.21–1.07) | 0.072 | 0.59 (1.33–7.47) | 0.275 |
| Non-hormonal | – | – | – | – |
| Intra-Uterine Devices | 1.66 (0.61–4.52) | 0.325 | 1.79 (0.57–5.57) | 0.316 |
| Education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 0.55 (0.28–1.09) | 0.085 | 0.88 (0.22–3.52) | 0.144 |
| Secondary incomplete | 1.67 (0.70–4.02) | 0.25 | 2.42 (0.34–17.15) | 0.408 |
| Secondary complete | 1.19 (0.57–2.45) | 0.646 | 2.84 (0.31–26.24) | 0.676 |
| College/University | 0.74 (0.33–1.65) | 0.457 | 2.15 (0.12–36.58) | 0.595 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 1.01 (0.32–3.18) | 0.988 | 0.15 (0.01–1.87) | 0.140 |
| Self-employed | 1.30 (0.41–4.09) | 0.653 | 0.33 (0.03–3.90) | 0.382 |
| Student | 1.64 (0.49–5.50) | 0.425 | 0.26 (0.02–3.53) | 0.313 |
| Other employment | 0.97 (0.19–5.03) | 0.973 | – | – |
| Average income | 1.00 (1.00–1.00) | 0.861 | 1.00 (1.00–1.00) | 0.920 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 1.06 (0.63–1.76) | 0.83 | 1.13 (0.45–2.83) | 0.798 |
| High | 1.43 (0.85–2.43) | 0.18 | 1.13 (0.38–3.33) | 0.829 |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 11 examines the determinants of elevated triglyceride levels (≥ 1.7 mmol/L). The results show that increasing age, increased the odds of having elevated triglycerides, this was at a Crude OR of 1.05 (95% CI: 1.01–1.08 p = 0.007) and at Adjusted OR 1.06 (95% CI: 1.01–1.11 p = 0.020), while persons in the high wealth quintile had increased odds of having elevated triglycerides, this was at an Adjusted OR of 2.22 (95% CI: 1.06–4.64 p = 0.035).
Table 11. Determinants of elevated triglycerides (≥ 1.7 mmol/L) among women aged 20–49 years in kirinyaga county (N = 425).
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 1.05 (1.01–1.08) | 0.007* | 1.06 (1.01–1.11) | 0.020* |
| Gravidity | 1.04 (0.86–1.26) | 0.708 | 0.79 (0.42–1.45) | 0.461 |
| Parity | 1.07 (0.87–1.31) | 0.524 | 1.09 (0.58–2.02) | 0.797 |
| Years of schooling | 0.99 (0.91–1.08) | 0.846 | 1.20 (0.97–1.49) | 0.088 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married/Cohabiting | 2.15 (0.74–6.25) | 0.160 | 2.20 (0.63–7.72) | 0.217 |
| Separated/Divorced/Widowed | 3.19 (1.00–10.17) | 0.050 | 2.72 (0.72–10.30) | 0.141 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 0.70 (0.39–1.24) | 0.217 | 0.81 (0.42–1.57) | 0.543 |
| Non-hormonal | 1.02 (0.20–5.14) | 0.979 | 0.80 (0.14–4.48) | 0.798 |
| Intra-Uterine Devices | 1.36 (0.60–3.10) | 0.460 | 1.35 (0.56–3.28) | 0.503 |
| Education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 0.69 (0.32–1.49) | 0.346 | 0.51 (0.21–1.28) | 0.151 |
| Secondary incomplete | 0.92 (0.38–2.23) | 0.859 | 0.60 (0.16–2.28) | 0.452 |
| Secondary completed | 0.68 (0.31–1.50) | 0.337 | 0.31 (0.07–1.39) | 0.126 |
| College/University | 0.63 (0.25–1.60) | 0.327 | 0.22 (0.03–1.59) | 0.133 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 0.76 (0.20–2.93) | 0.693 | 0.64 (0.14–2.79) | 0.548 |
| Self-employed | 0.86 (0.23–3.25) | 0.82 | 0.81 (0.18–3.76) | 0.792 |
| Student | 0.66 (0.16–2.71) | 0.561 | 0.61 (0.12–3.01) | 0.541 |
| Other employment | – | – | – | – |
| Average income | 1.00 (1.00–1.00) | 0.696 | 1.00 (1.00–1.00) | 0.286 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 1.10 (0.58–2.10) | 0.762 | 1.18 (0.60–2.34) | 0.632 |
| High | 1.51 (0.81–2.79) | 0.194 | 2.22 (1.06–4.64) | 0.035* |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
Table 12 presents the determinants of the metabolic syndrome. The results show that increasing age, gravidity, and parity influenced the metabolic syndrome; age increased the odds of developing the metabolic syndrome at a crude OR of 1.05 (95%CI: 1.02–1.07, p = 0.001), and at an adjusted OR of 1.04 (1.01 -1.08, p = 0.020). At the same time, gravidity increased the odds of developing metabolic syndrome by 1.16 times, and parity by 1.22 times, with crude ORs of 1.16 (95% CI: 1.00–1.35, p = 0.046) and 1.22 (1.04–1.43, p = 0.015), respectively. Persons who had completed primary school also had lower odds of developing metabolic syndrome, with a crude OR of 0.54 (0.29–0.99, p = 0.048). Among students and persons in informal employment, the odds of developing metabolic syndrome were lower. For students, the crude OR was 0.27 (95% CI: 0.08–0.94, p = 0.04) and the adjusted OR was 0.24 (95% CI: 0.06–0.98, p = 0.047). For persons in informal employment, the crude OR was 0.13 (95% CI: 0.02–0.76, p = 0.024). Persons in the highest wealth quintile were also more likely to develop metabolic syndrome, with an adjusted OR of 1.79 (95% CI: 1.03–3.14, p = 0.040).
Table 12. Determinants of the metabolic syndrome among women aged 20–49 in kirinyaga county, Kenya.
| Variable | Crude OR (95% CI) | p-value | Adjusted OR (95% CI) | p-value |
|---|---|---|---|---|
| Age (years) | 1.05 (1.02–1.07) | 0.001* | 1.04 (1.01–1.08) | 0.020* |
| Gravidity | 1.16 (1.00–1.35) | 0.046* | 0.83 (0.56–1.22) | 0.429 |
| Parity | 1.22 (1.04–1.43) | 0.015* | 1.30 (0.84–2.01) | 0.343 |
| Years of schooling | 0.97 (0.91–1.03) | 0.36 | 0.99 (0.84–1.16) | 0.885 |
| Marital status | ||||
| Never married | Reference | – | Reference | – |
| Currently married/Cohabiting | 1.74 (0.91–3.33) | 0.092 | 1.49 (0.65–3.42) | 0.344 |
| Separated/ Divorced/ Widowed | 1.61 (0.71–3.63) | 0.254 | 1.11 (0.45–2.77) | 0.820 |
| Family planning use | ||||
| None | Reference | – | Reference | – |
| Hormonal | 0.68 (0.44–1.06) | 0.086 | 0.67 (0.40–1.13) | 0.135 |
| Non-hormonal | 1.43 (0.38–5.31) | 0.598 | 1.02 (0.24–4.23) | 0.982 |
| Intra-Uterine Devices | 1.25 (0.62–2.51) | 0.531 | 0.95 (0.45–2.02) | 0.893 |
| Education | ||||
| Primary incomplete | Reference | – | Reference | – |
| Primary completed | 0.54 (0.29–0.99) | 0.048* | 0.61 (0.29–1.28) | 0.192 |
| Secondary incomplete | 0.85 (0.41–1.74) | 0.651 | 1.45 (0.49–4.31) | 0.505 |
| Secondary complete | 0.62 (0.33–1.16) | 0.136 | 1.02 (0.30–3.49) | 0.979 |
| College/University | 0.61 (0.30–1.25) | 0.174 | 0.92 (0.19–4.33) | 0.911 |
| Employment | ||||
| Government employee | Reference | – | Reference | – |
| Non-government employee | 0.32 (0.10–1.06) | 0.063 | 0.28 (0.07–1.04) | 0.057 |
| Self-employed | 0.40 (0.12–1.34) | 0.139 | 0.44 (0.11–1.70) | 0.233 |
| Student | 0.27 (0.08–0.94) | 0.04* | 0.24 (0.06–0.98) | 0.047* |
| Informal employment | 0.13 (0.02–0.76) | 0.024* | 0.26 (0.04–1.69) | 0.156 |
| Average income | 1.00 (1.00–1.00) | 0.685 | 1.00 (1.00–1.00) | 0.643 |
| Wealth quintile | ||||
| Low | Reference | – | Reference | – |
| Middle | 0.88 (0.55–1.41) | 0.596 | 0.92 (0.56–1.53) | 0.752 |
| High | 1.33 (0.83–2.12) | 0.235 | 1.79 (1.03–3.14) | 0.040* |
OR, odds ratio; CI, confidence interval; AOR, adjusted odds ratio.
p ≤ 0.05.
4 Discussion
This study aimed to determine the prevalence of four metabolic risk factors for noncommunicable diseases, as mapped out by the World Health Organization (1), and the prevalence of metabolic syndrome according to the JIS criteria (2) among women aged 20–49 years in Kirinyaga County, and to examine the sociodemographic determinants associated with these risks.
The prevalence of obesity and overweight in Kirinyaga County was 4.27% higher than the data presented in the 2022 Demographic and Health Survey (11). This study's results reveal that central obesity exceeds obesity by BMI. This trend, in which central obesity exceeds obesity by BMI, has also been observed in Nairobi County, Kenya (24). Central obesity, characterised by the accumulation of visceral fat, is a risk factor for cardiometabolic health, a better predictor of cardiovascular risk and mortality, and a primary contributor to elevated blood glucose, hypertension, and dyslipidemia (25). Biologically, increasing age increases the likelihood of both central obesity and obesity-related BMI, consistent with studies conducted in South Africa, Sub-Saharan Africa and low and middle-income countries (17, 26, 27). Ageing is associated with increased adiposity, as metabolism slows and the beneficial effects of estrogen through its receptors weaken in fat tissue (27). Higher parity and gravidity also increased the likelihood of abdominal obesity and obesity-related BMI, consistent with data from low and middle-income countries (26). Dietary habits and reduced physical activity during the prepartum and postpartum periods often lead to weight gain, which accumulates across pregnancies (28, 29).
Socio-demographically, marital separation increased the prevalence of being obese, agreeing with a study in Mali (30) and differing with studies in Kenya and Tanzania (28, 31), where married women had a higher likelihood of being overweight or obese. While marriage-associated obesity has been linked to a sense of security and peace of mind (32), the high prevalence of obesity among separated women may stem from stress eating. Socio-economically, in Kirinyaga County, informal employment reduced the odds of becoming obese, while in Tanzania, the odds were increased (28). Being in the high and middle-income wealth quintiles also increased the odds of becoming obese, consistent with studies from South Africa and low and middle-income countries (17, 26). The association between increasing wealth and obesity may result from greater capacity to purchase and consume energy-dense foods (28). An increase in years of schooling was also associated with a reduction in abdominal obesity in this study; this was in agreement with a study in Southeastern Turkey (33), where higher levels of education decreased obesity, as measured by BMI, but was contradictory to South Africa and Sub-Saharan Africa, where the prevalence of obesity by BMI is higher in more educated women (17, 27). The reduction in obesity, among women with higher levels of education in this study, might be because education has been shown to increase awareness of personal health, and individuals are more likely to shift to and practice healthier lifestyles (33). Obesity not only predisposes affected individuals to multi-morbidities, but it also has a major economic impact, resulting in losses of 0.8% to 2.4% of the gross domestic product (34). By 2035, 3% of global GDP is projected to be devoted to managing obesity (35).
In Kirinyaga County, 63.8% of the women had elevated fasting glucose, with 55.25% being pre-diabetic and 8.56% being diabetic. In the Kenyan demographic health survey, 1% of the women of reproductive age have been diagnosed with diabetes, and 63% were currently on treatment for diabetes. The observed contrast is likely due to the study's use of more accurate fasting blood glucose measurements, which avoid postprandial fluctuations in random blood glucose measurements (36). Improper and incorrect management of prediabetes usually leads to insulin resistance, which progresses to Type 2 diabetes (37, 38). Type 2 diabetes damages vital organs, including the retina, liver, and kidneys (38, 39). In this study, increasing age increased the odds of having elevated fasting glucose; age-related declines in glucose effectiveness and insulin secretory capacity drive this trend (40). Hormonal contraceptive use was associated with lower odds of elevated blood glucose, consistent with findings in the US (41). However, it was in contrast to studies in Ethiopia (42) and other cohorts where long-term use of hormonal contraceptives (43) or use of specific androgenic progestogens (44) was linked to increased fasting glucose and insulin resistance. The divergent findings might suggest a healthy-user effect, in which women accessing family services benefit from healthcare interactions and screening, which help mitigate metabolic risk factors. Socio-economically, individuals with higher educational status had lower odds of developing elevated blood glucose, consistent with a study in Korea (45). The reduced risk might be due to the positive correlation between educational attainment and health literacy (45). Type 2 diabetes cost Kenya USD 635 million in 2021, with projections reaching USD 1.6 billion by 2045 (46).
The prevalence of elevated blood pressure in our study was 2% higher than that reported in the 2022 DHS data (11). The persistent elevation in arterial blood pressure leads to hypertension, a key risk factor for cardiovascular morbidity and mortality, and a precursor to the metabolic syndrome (47, 48). Consequences of uncontrolled blood pressure include heart failure, heart attacks, strokes, aneurysms, kidney problems, and eye problems (48). In this study, hypertension was associated with increasing age, consistent with studies in Sub-Saharan Africa (49). Age-related changes in the arterial walls and reductions in physical activity are probably the main determinants of this change (50). Gravidity and parity also increased the likelihood of developing hypertension in this study; this aligned with studies from Sudan and Iran (51, 52). Multi-parity increases exposure to various physiological changes, including weight gain, dyslipidemia, insulin resistance, elevated plasma glucose and endothelial dysfunction (16, 52). However, extended breastfeeding may help to mitigate the risks by releasing oxytocin and mobilising lipids (16). In our study, the use of hormonal contraceptive methods reduced the odds of developing hypertension. Systematic reviews indicate that the effects of hormonal contraception vary by composition combinations (53) and delivery methods, with vaginal rings and hormonal intrauterine devices reducing blood pressure, while injectables increase it (53). Socio-demographically, married women also had a higher likelihood of developing hypertension, which agreed with a study in Lesotho, Bangladesh and India (15, 50, 54), possibly due to marital stress. Socio-economically, higher education was associated with reduced odds of hypertension, aligning with data from India (50) but differing from data from Bangladesh (15). In Kenya, the annual cost per patient for hypertension management was USD 304.8, with medications accounting for the largest share at USD 168 (55). This was similar to other studies in sub-Saharan Africa, where hypertension medications accounted for the lion's share of expenditure (56).
Dyslipidemia is responsible for up to 4 million deaths annually and is a major risk factor for ischemic heart disease (8). In this study, dyslipidemia was characterised by a high prevalence of low HDL-C, elevated triglycerides and elevated cholesterol. Compared with the 2015 stepwise survey in Kenya, the prevalence of elevated cholesterol decreased to 13%, while the prevalence of low HDL-C increased to 60% (57). Biologically, increasing age in this study was associated with elevated cholesterol and triglyceride levels, which aligns with studies in Tunisia and China (58, 59). Ageing progressively impairs the absorption, production, and metabolism of fats and lipoproteins (58, 59). Regarding reproductive health, the use of hormonal family planning methods and intrauterine devices was associated with increased odds of having low high-density lipoprotein, which is in agreement with data from Ethiopia and Iran that link these methods to adverse elevations in cholesterol and triglycerides (60–62). Socio-demographically, marital status influenced the lipid profile; separated and divorced women were less likely to have low HDL-C, while women who were previously married had reduced odds of having elevated cholesterol. Marriage is linked to increased triglycerides in Taiwan (63) and dyslipidemia in China (64). Marriage confers a protective effect against cardiovascular disease (65), but this effect depends on relationship stability, as strain erodes its protective benefits (66). Socio-economically, women in the high wealth quintile had higher odds of having elevated triglycerides. This finding mirrors those in Brazil, where high SES correlated with multiple lipid abnormalities (75), but differs from Iran, where women in low SES also had higher triglyceride levels (66).
The prevalence of metabolic syndrome (MetS) in Kirinyaga County, at 46.4%, was significantly higher than the rates reported amongst women of reproductive age in Kenya, Uganda and South Africa (13, 18, 19). MetS elevates the risk of cardiovascular events, and persons with it are five times more likely to develop Type 2 diabetes (13). Age, a natural biological marker, was also associated with a higher odds of metabolic syndrome, consistent with other studies from Kenya and South Africa (13, 18). Ageing has been shown to increase the risk of metabolic disorders due to physiological changes, including reduced metabolic rate, hormonal shifts, and altered body composition (67). Interestingly, the development of metabolic syndrome also accelerates the ageing process in individuals, due to the excess reactive oxygen species present in this condition (68). Increased parity and gravidity in this study were also associated with an increased risk of developing metabolic syndrome, this was in alignment with a meta-analysis that indicated a 12% risk increase per live birth (69), as a result of physiological changes, including weight gain, changes in cholesterol distribution, insulin resistance, and high blood sugar levels (52), that accumulate with multiple pregnancies (69). Socio-economically, completing primary school reduced the odds of developing metabolic syndrome, consistent with data from South Africa (18). This trend suggests that education might be increasing health literacy. Employment and wealth patterns also varied, with students and informal workers having lower odds of developing metabolic syndrome, a finding in agreement with studies in South Africa (18) and China (70). Individuals in the highest wealth quintile were more likely to develop metabolic syndrome in this study, a finding that contrasts with trends in South Africa (18) and China (70). The positive association between wealth and the metabolic syndrome is most likely a reflection of the nutrition transition in developing economies, where higher SES facilitates the consumption of energy-dense, processed foods and sedentary behaviours, unlike in high-income economies, where affluence is typically associated with better health behaviours and lower disease risk (71).
It is critical to acknowledge that this study was cross-sectional and, therefore, presents a snapshot of the picture at a single point in time. It might not provide causality and can only show associations. It was also limited to Kirinyaga County, which is predominantly agricultural. Therefore, it might not be possible to generalise the data to arid or semi-arid regions in Kenya or to highly urbanised regions. The limitations of the study, however, are mitigated by the simultaneous collection of data on both anthropometric and biochemical parameters, which allows for a more precise assessment of individuals’ true metabolic health. The utilisation of fasting blood glucose also helped capture and record participants who would normally be missed when using a random blood sugar measurement. The study's unique focus on a healthy population and the metabolic syndrome also presents an excellent opportunity for interventions that can reverse these risk factors before the development of non-communicable diseases. Consequently, this study fills a significant data gap regarding the epidemiological transition of non-communicable diseases in rural and peri-urban Kenya, providing a solid evidence base for county-level policy formulation.
To reduce the high prevalence of metabolic syndrome and associated risk factors, different policies can be implemented and enforced. At the county level, efforts should focus on increasing the mobilisation of funds for preventive screenings and public health programs to address the nutrition transition. At the national level, Kenya has an NCD strategic plan (72) that outlines multi-sectoral actions to reduce the NCD burden. However, it does not explicitly identify women aged 20–49 as a high-risk group; this should be revised to acknowledge that metabolic health is vital for both maternal survival and the prevention of intergenerational disease transmission. In addition, the social health authority should include an annual, mandatory, and free wellness package for women of reproductive age to facilitate screening for metabolic health. This study points to parity, gravidity, and family planning as key determinants of metabolic risk factors; therefore, prenatal, postnatal, and family planning clinics offer a unique opportunity for the early detection and opportunistic screening for these risk factors and metabolic syndrome. This approach utilises the healthy user effect observed in contraceptive users. The connection between marriage, separation, and adverse metabolic outcomes emphasises the need for gender sensitive interventions that address the psychosocial determinants of health. Policymakers should also invest in qualitative studies to understand the social barriers women face. To sustain these interventions, community health promoters, who are identified as Level 1 providers by the Kenya Community Health Strategy 2020–2025 (73), yet remain under-equipped, should be continuously trained and equipped with functional diagnostic tools to conduct household-level surveillance. This approach enables the early identification of some metabolic risk factors for non-communicable diseases.
5 Conclusion
The high prevalence of the metabolic syndrome at 46.4% alongside the high rates of obesity, central adiposity, elevated fasting glucose, elevated blood pressure, and dyslipidemia indicates that women of reproductive age in Kirinyaga County might be at an increased risk of developing non-communicable diseases later in life. Biologically, increasing age was identified as a key risk factor; a look at the reproductive factors shows that multi-parity was also a key factor, which reflects the cumulative impact of reproductive stress on women. When it came to the socio-economic determinants, while the attainment of education offered protection, most likely through improved health literacy, persons in the highest wealth quintiles had an increased risk of both obesity and the metabolic syndrome. This paradox aligns with the nutrition model, which theorises that economic affluence in developing countries facilitates sedentary lifestyles and the consumption of calorie-dense diets. This study diverged from global trends regarding family planning choices and marital status. Hormonal contraceptive use was associated with a favourable glucose and lipid profile, suggesting the prevalence of newer-generation, metabolically neutral formulations in this region or a potential healthy-user effect, in which increased healthcare interactions and screening among women accessing family planning services mitigate the effects of these risk factors. On the other hand, the state of the marital union also had an impact on the metabolic risk factors, where marriage and separation were associated with negative outcomes in domestic and psychosocial stress on women's metabolic health. The findings of this study show the need for public health interventions that go beyond general awareness and address the unique intersection of wealth, parity, and stress in this population.
Generative AI statement
The author(s) declared that generative AI was not used in the creation of this manuscript.
Any alternative text (alt text) provided alongside figures in this article has been generated by Frontiers with the support of artificial intelligence and reasonable efforts have been made to ensure accuracy, including review by the authors wherever possible. If you identify any issues, please contact us.
Publisher's note
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.
Supplementary material
The Supplementary Material for this article can be found online at: https://www.frontiersin.org/articles/10.3389/fepid.2026.1807836/full#supplementary-material
Supplementary material Supplementary material at the source
Supplementary material Supplementary material at the source
Footnotes
Edited by: Ioanna Kontele, University of West Attica, Greece
Reviewed by: Dimakatso Given Mashala, University of Limpopo, South Africa
Madhurima D, SRM Institute of Science and Technology (Deemed to be University) College of Nursing, India
Statements
- Conflict of interest
The author(s) declared that this work was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
- Funding
The author(s) declared that financial support was not received for this work and/or its publication.
- Data availability
The original contributions presented in the study are included in the article/Supplementary Material, further inquiries can be directed to the corresponding author.
- Ethics approval
The study involved humans and was approved by the JKUAT Institutional Scientific and Ethics Review Committee (ISEREC) JKU/ISERC/02316/1727. Ethical permission was also granted by the National Commission for Science, Technology, and Innovation (NACOSTI), Kenya, license no: NACOSTI/P/25/4174059. The study was conducted in accordance with the local legislation and institutional requirements. The participants provided their written informed consent to participate in this study. Each Study participant confirmed their willingness to participate by signing an informed consent form.
- Author contributions
UM: Writing – original draft, Writing – review & editing, Conceptualization, Data curation, Formal analysis, Funding acquisition, Investigation, Methodology, Project administration, Resources, Software, Validation, Visualization. FK: Conceptualization, Methodology, Resources, Supervision, Validation, Writing – review & editing. DO: Conceptualization, Methodology, Resources, Supervision, Validation, Writing – review & editing. ZN: Conceptualization, Methodology, Resources, Supervision, Validation, Writing – review & editing. BK: Conceptualization, Methodology, Resources, Supervision, Validation, Writing – review & editing. VW: Formal analysis, Methodology, Software, Supervision, Validation, Writing – review & editing.
- Acknowledgements
We express our sincere gratitude to all participants who took part in this study for their time and cooperation. We acknowledge the Kirinyaga County Health Management Team for their support during this study. Special thanks to Dr. Esbon Gakuo, the Director of Health, Kirinyaga County, Mr. Dennis Murimi – The County Nutrition Coordinator, Mr. Simon Kariuki – The NCD Coordinator, Mr. Kagiri Mbatia – The County Lab Coordinator, and Madam Margaret Wahito – the County Focal Person.
References
- 1. World Health Organisation. Noncommunicable diseases. Available online at: (Accessed May 18, 2026)
- 2. Alberti KGMM, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA. Harmonising the metabolic syndrome: a joint interim statement of the international diabetes federation task force on epidemiology and prevention; national heart, lung, and blood institute; American Heart Association; world heart federation; international atherosclerosis society; and international association for the study of obesity. Circulation. (2009) 120 (16): 1640 – 5. doi:10.1161/CIRCULATIONAHA.109.192644
- 3. Phelps NH, Singleton RK, Zhou B, Heap RA, Mishra A, Bennett JE. Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults. Lancet. (2024) 403 (10431): 1027 – 50. doi:10.1016/S0140-6736(23)02750-2
- 4. World Health Organisation. Diabetes. Available online at: (Accessed January 30, 2026)
- 5. Global report on hypertension. High stakes: turning evidence into action (2025). Available online at: (Accessed January 30, 2026)
- 6. Ballena-Caicedo J, Zuzunaga-Montoya FE, Loayza-Castro JA, Vásquez-Romero LEM, Tapia-Limonchi R, De Carrillo CIG. Global prevalence of dyslipidemias in the general adult population: a systematic review and meta-analysis. J Health Popul Nutr. (2025) 44 (1): 308. doi:10.1186/s41043-025-01054-3
- 7. Gona PN, Kimokoti RW, Gona CM, Ballout S, Rao SR, Mapoma CC. Changes in body mass index, obesity, and overweight in Southern Africa development countries, 1990 to 2019: findings from the global burden of disease, injuries, and risk factors study. Obes Sci Pract. (2021) 7 (5): 509 – 24. doi:10.1002/osp4.519
- 8. Obsa MS, Ataro G, Awoke N, Jemal B, Tilahun T, Ayalew N. Determinants of dyslipidemia in Africa: a systematic review and meta-analysis. Front Cardiovasc Med. (2022) 8: 778891. doi:10.3389/fcvm.2021.778891
- 9. Noubiap JJ, Nansseu JR, Nyaga UF, Ndoadoumgue AL, Ngouo AT, Tounouga DN. Worldwide trends in metabolic syndrome from 2000 to 2023: a systematic review and modelling analysis. Nat Commun. (2025) 17 (1): 573. doi:10.1038/s41467-025-67268-5
- 10. Bowo-Ngandji A, Kenmoe S, Ebogo-Belobo JT, Kenfack-Momo R, Takuissu GR, Kengne-Ndé C. Prevalence of the metabolic syndrome in African populations: a systematic review and meta-analysis. PLoS One. (2023) 18 (7): e0289155. doi:10.1371/journal.pone.0289155
- 11. Kenya Demographic and Health Survey - 2022 - Kenya National Bureau of Statistics [Internet]. [cited 2026 January 3]. Available online at:
- 12. Mbau L, Fourie JM, Scholtz W, Scarlatescu O, Nel G, Gathecha G. PASCAR And WHF cardiovascular diseases scorecardproject. Cardiovasc J Afr. (2021) 32: 51 – 7. doi:10.5830/CVJA-2021-022
- 13. Omuse G, Maina D, Hoffman M, Mwangi J, Wambua C, Kagotho E. Metabolic syndrome and its predictors in an urban population in Kenya: a cross sectional study. BMC Endocr Disord. (2017) 17 (1): 37. doi:10.1186/s12902-017-0188-0
- 14. Brauer M, Roth GA, Aravkin AY, Zheng P, Abate KH, Abate YH. Global burden and strength of evidence for 88 risk factors in 204 countries and 811 subnational locations, 1990–2021: a systematic analysis for the global burden of disease study 2021. Lancet. (2024) 403 (10440): 2162 – 203. doi:10.1016/S0140-6736(24)00933-4
- 15. Chowdhury SR, Islam MN, Sheekha TA, Kader SB, Hossain A. Prevalence and determinants of noncommunicable diseases risk factors among reproductive-aged women: findings from a nationwide survey in Bangladesh. PLoS One. (2023) 18 (6): e0273128. doi:10.1371/journal.pone.0273128
- 16. Shih YH, Bryan MS, Parvez F, Uesugi KH, Shahriar M, Ahmed A. Gravidity, parity, blood pressure and mortality among women in Bangladesh from the HEALS cohort. BMJ Open. (2020) 10 (8): e037244. doi:10.1136/bmjopen-2020-037244
- 17. Nglazi MD, Ataguba JEO. Overweight and obesity in non-pregnant women of childbearing age in South Africa: subgroup regression analyses of survey data from 1998 to 2017. BMC Public Health. (2022) 22 (1): 395. doi:10.1186/s12889-022-12601-6
- 18. Mashala DG, Ntimana CB, Seakamela KP, Mashaba RG, Maimela E. Sociodemographic disparities in the prevalence of metabolic syndrome in rural South Africa: an analysis of gender, age, and marital, employment, and educational Status. Obesities. (2024) 4 (4): 480 – 90. doi:10.3390/obesities4040038
- 19. Lubogo D, Wamani H, Mayega RW, Orach CG. Effects of nutrition education, physical activity and motivational interviewing interventions on metabolic syndrome among females of reproductive age in wakiso district, central Uganda: a randomised parallel-group trial. BMC Public Health. (2025) 25 (1): 790. doi:10.1186/s12889-025-21936-9
- 20. Were V, Foley L, Turner-Moss E, Mogo E, Wadende P, Musuva R. Comparison of household socioeconomic status classification methods and effects on risk estimation: lessons from a natural experimental study, kisumu, western Kenya. Int J Equity Health. (2022) 21 (1): 47. doi:10.1186/s12939-022-01652-1
- 21. Obesity: preventing and managing the global epidemic. Report of a WHO consultation. World Health Organ Tech Rep Ser. (2000) 894: 1 – 253.
- 22. Waist circumference and waist-hip ratio: report of a WHO expert consultation. Available online at: (Accessed December 8, 2025)
- 23. American Diabetes Association Professional Practice Committee. 2. Diagnosis and classification of diabetes: standards of care in diabetes—2025. Diabetes Care. (2024) 48 (Supplement_1): S27 – 49. doi:10.2337/dc25-S002
- 24. Mohamed SF, Haregu TN, Khayeka-Wandabwa C, Muthuri SK, Kyobutungi C. Magnitude and predictors of normal-weight central obesity– the AWI-gen study findings. Glob Health Action. (2019) 12 (1): 1685809. doi:10.1080/16549716.2019.1685809
- 25. Swarup S, Ahmed I, Grigorova Y, Zeltser R. Metabolic Syndrome. In: StatPearls. Treasure Island (FL): StatPearls Publishing (2024). Available online at: (Accessed September 9, 2024)
- 26. Alem AZ, Yeshaw Y, Liyew AM, Tessema ZT, Worku MG, Tesema GA. Double burden of malnutrition and its associated factors among women in low and middle income countries: findings from 52 nationally representative data. BMC Public Health. (2023) 23 (1): 1479. doi:10.1186/s12889-023-16045-4
- 27. Owobi O, Okonji O, Nzoputam C, Ekholuenetale M. Country-Level variations in overweight and obesity among reproductive-aged women in sub-saharan countries. Women. (2022) 2 (4): 313 – 25. doi:10.3390/women2040029
- 28. Mosha D, Paulo HA, Mwanyika-Sando M, Mboya IB, Madzorera I, Leyna GH. Risk factors for overweight and obesity among women of reproductive age in Dar es Salaam, Tanzania. BMC Nutr. (2021) 7 (1): 37. doi:10.1186/s40795-021-00445-z
- 29. Dagnaw M, Mekonnen M, Muhammad EA, Abebe SM. Prevalence and associated factors of overweight/obesity among women in the reproductive age group (15–49) in gondar town, northwest Ethiopia, 2022: a cross-sectional study. Health Sci Rep. (2025) 8 (5): e70810. doi:10.1002/hsr2.70810
- 30. Seidu AA, Ahinkorah BO, Agbaglo E, Nyaaba AA. Overweight and obesity among women of reproductive age in Mali: what are the determinants? Int Health. (2021) 13 (5): 428 – 35. doi:10.1093/inthealth/ihaa094
- 31. Mkuu R, Barry A, Yonga G, Nafukho F, Wernz C, Gilreath T. Prevalence and factors associated with overweight and obesity in Kenya. Prev Med Rep. (2021) 22: 101340. doi:10.1016/j.pmedr.2021.101340
- 32. Nikolic Turnic T, Jakovljevic V, Strizhkova Z, Polukhin N, Ryaboy D, Kartashova M. The association between marital Status and obesity: a systematic review and meta-analysis. Diseases. (2024) 12 (7): 146. doi:10.3390/diseases12070146
- 33. Şahin T, Borlu A. Prevalence of obesity in women of reproductive age group and related factors. A study from southeastern Turkey. Niger J Clin Pract. (2022) 25 (6): 801 – 8. doi:10.4103/njcp.njcp_1587_21
- 34. Lam BCC, Lim AYL, Chan SL, Yum MPS, Koh NSY, Finkelstein EA. The impact of obesity: a narrative review. Singapore Med J. (2023) 64 (3): 163 – 71. doi:10.4103/singaporemedj.SMJ-2022-232
- 35. Ahmed SK, Mohammed RA. Obesity: prevalence, causes, consequences, management, preventive strategies and future research directions. Metab Open. (2025) 27: 100375. doi:10.1016/j.metop.2025.100375
- 36. NIHR Dissemination Centre. Comparing blood tests to detect diabetes during NHS health checks (2015). Available online at: (Accessed October 27, 2025)
- 37. Bkaily G, Jazzar A, Abou-Aichi A, Jacques D. Pathophysiology of prediabetes hyperinsulinemia and insulin resistance in the cardiovascular system. Biomedicines. (2025) 13 (8): 1842. doi:10.3390/biomedicines13081842
- 38. Ping WX, Hu S, Su JQ, Ouyang SY. Metabolic disorders in prediabetes: from mechanisms to therapeutic management. World J Diabetes. (2024) 15 (3): 361 – 77. doi:10.4239/wjd.v15.i3.361
- 39. Lawal Y, Bello F, Kaoje YS. Prediabetes deserves more attention: a review. Clin Diabetes. (2020) 38 (4): 328 – 38. doi:10.2337/cd19-0101
- 40. Huang LY, Liu CH, Chen FY, Kuo CH, Pitrone P, Liu JS. Aging affects insulin resistance, insulin secretion, and glucose effectiveness in subjects with normal blood glucose and body weight. Diagnostics. (2023) 13 (13): 2158. doi:10.3390/diagnostics13132158
- 41. Yao W, Dong X, Yu X, Luo J, Zhang D. The use of oral contraceptive is inversely associated with the risk of type 2 diabetes mellitus among middle-aged women. Gynecol Endocrinol. (2021) 37 (8): 758 – 63. doi:10.1080/09513590.2021.1932802
- 42. Kofole Z, Haile D, Solomon Y. Fasting blood glucose, blood pressure and body mass index among combined oral contraceptive users in chencha town southern Ethiopia, 2019. Front Glob Womens Health. (2023) 4: 992750. doi:10.3389/fgwh.2023.992750
- 43. Mosorin M, Ollila M, Nordström T, Jokelainen J, Piltonen T, Auvinen J. Former long-term use of combined hormonal contraception and glucose metabolism disorders in perimenopausal women: a prospective, population-based cohort study. Acta Obstet Gynecol Scand. (2023) 102 (11): 1488 – 95. doi:10.1111/aogs.14636
- 44. Cree JME, Brennan NM, Poppitt SD, Miles-Chan JL. The effect of the oral contraceptive pill on acute glycaemic response to an oral glucose bolus in healthy young women: a randomised crossover study. Nutrients. (2024) 16 (20): 3490. doi:10.3390/nu16203490
- 45. Lee MJ, Seo BJ, Kim YS. Impact of education as a social determinant on the risk of type 2 diabetes Mellitus in Korean adults. Healthcare. (2024) 12 (14): 1446. doi:10.3390/healthcare12141446
- 46. Karugu CH, Agyemang C, Ilboudo PG, Boachie MK, Mburu L, Wanjohi M. The economic burden of type 2 diabetes on the public healthcare system in Kenya: a cost of illness study. BMC Health Serv Res. (2024) 24 (1): 1228. doi:10.1186/s12913-024-11700-x
- 47. Stanciu S, Rusu E, Miricescu D, Radu AC, Axinia B, Vrabie AM. Links between metabolic syndrome and hypertension: the relationship with the current antidiabetic drugs. Metabolites. (2023) 13 (1): 87. doi:10.3390/metabo13010087
- 48. Chekol HR, Demissie NG, Mekonnen CK. Awareness of hypertension-related complications and its determinants among adult hypertensive patients in Ethiopia. Front Cardiovasc Med. (2025) 12: 1563249. doi:10.3389/fcvm.2025.1563249
- 49. Gafane-Matemane LF, Craig A, Kruger R, Alaofin OS, Ware LJ, Jones ESW. Hypertension in sub-saharan Africa: the current profile, recent advances, gaps, and priorities. J Hum Hypertens. (2024) 39: 95 – 110. doi:10.1038/s41371-024-00913-6
- 50. Virk A, Samdarshi N, Saini P, Mohapatra A, Sahoo S, Goel S. Prevalence and determinants of hypertension and associated comorbidities in non-pregnant women of reproductive age group (15–49 years): evidence from national family health survey (NFHS-4), India. J Fam Med Prim Care. (2022) 11 (9): 5865 – 73. doi:10.4103/jfmpc.jfmpc_162_22
- 51. Musa IR, Osman OE, Adam I. The association between parity and hypertension: a cross-sectional, community-based study. Front Cardiovasc Med. (2023) 10: 1247244. doi:10.3389/fcvm.2023.1247244
- 52. Moazzeni SS, Asgari S, Azizi F, Hadaegh F. Live birth/parity number and the risk of incident hypertension among parous women during over 13 years of follow-up. J Clin Hypertens. (2021) 23 (11): 2000 – 8. doi:10.1111/jch.14369
- 53. Kalenga CZ, Dumanski SM, Metcalfe A, Robert M, Nerenberg KA, MacRae JM. The effect of non-oral hormonal contraceptives on hypertension and blood pressure: a systematic review and meta-analysis. Physiol Rep. (2022) 10 (9): e15267. doi:10.14814/phy2.15267
- 54. Lebuso M, De Wet- Billings N. The prevalence and sociodemographic correlates of hypertension among women (15–49 years) in Lesotho: a descriptive analysis. BMC Public Health. (2022) 22 (1): 562. doi:10.1186/s12889-022-12960-0
- 55. Oyando R, Njoroge M, Nguhiu P, Kirui F, Mbui J, Sigilai A. Patient costs of hypertension care in public health care facilities in Kenya. Int J Health Plann Manage. (2019) 34 (2): e1166 – 78. doi:10.1002/hpm.2752
- 56. Gnugesser E, Chwila C, Brenner S, Deckert A, Dambach P, Steinert JI. The economic burden of treating uncomplicated hypertension in sub-saharan Africa: a systematic literature review. BMC Public Health. (2022) 22 (1): 1507. doi:10.1186/s12889-022-13877-4
- 57. Kenya. Kenya Stepwise Survey for Non Communicable Diseases Risk Factors 2015. Available online at: (Accessed October 30, 2025)
- 58. Ben Cherifa F, El Ati J, Doggui R, El Ati-Hellal M, Traissac P. Prevalence of high HDL cholesterol and its associated factors among Tunisian women of childbearing age: a cross-sectional study. Int J Environ Res Public Health. (2021) 18 (10): 5461. doi:10.3390/ijerph18105461
- 59. Feng L, Nian S, Tong Z, Zhu Y, Li Y, Zhang C. Age-related trends in lipid levels: a large-scale cross-sectional study of the general Chinese population. BMJ Open. (2020) 10: e034226. doi:10.1136/bmjopen-2019-034226
- 60. Turki A, Ayalew A, Mossie A, Mitiku S. Effects of hormonal contraceptives on lipid profile among women attending family planning unit in goba town public health facilities, bale, southeast Ethiopia: a comparative cross-sectional study. Reprod Health. (2023) 20 (1): 185. doi:10.1186/s12978-023-01727-4
- 61. Shiferaw M, Kassahun W, Zawdie B. Anthropometric indices, blood pressure, and lipid profile status among women using progestin-only contraceptives: comparative cross-sectional study. BMC Womens Health. (2021) 21 (1): 34. doi:10.1186/s12905-021-01178-8
- 62. Hashemi SJ, Khezri R, Saki N, Nasehi N, Hosseini SA, Harizi M. Association between oral contraceptives with lipid profile: results from hoveyzeh cohort study (HCS). BMC Womens Health. (2023) 23 (1): 552. doi:10.1186/s12905-023-02703-7
- 63. Chen YH, Lin JJ, Tang HM, Yang CW, Jong GP, Yang YS. Relationship between marriage and prediabetes among healthcare workers: mediating effect of triglycerides. Medicina (Mex). (2024) 60 (9): 1418. doi:10.3390/medicina60091418
- 64. Wang W, Li X, Lv D, Wu X, Xie F, Xie W. Analysing lipid profiles and dyslipidemia prevalence in hypertensive patients: a cross-sectional study from primary community health institutions. Front Med. (2024) 11: 1425414. doi:10.3389/fmed.2024.1425414
- 65. Smith TW. Intimate relationships and coronary heart disease: implications for risk, prevention, and patient management. Curr Cardiol Rep. (2022) 24 (6): 761 – 74. doi:10.1007/s11886-022-01695-4
- 66. Izadi N, Yari-Boroujeni R, Soofi M, Niknam M, Amiri P, Najafi F. Socioeconomic inequalities and dyslipidaemia in adult population of the ravansar noncommunicable disease cohort study: the role of sex and age. BMJ Open. (2024) 14: e085035. doi:10.1136/bmjopen-2024-085035
- 67. Ataei SMN, Sheidaei A, Golestani A, Khosravi S, Rashidi MM, Tabatabaei-Malazy O. Over-time changes in the prevalence of metabolic syndrome and its components among elderly population in Iran from 2016 to 2021; A nation-wide study. PLoS One. (2025) 20 (9): e0331601. doi:10.1371/journal.pone.0331601
- 68. Goddard G, Rajagopal S, Wahbah Makhoul G, Raji MA. Metabolic syndrome in older adults: through the Lens of institute for healthcare improvement’s (IHI) 4Ms framework and social determinants of health. Life. (2025) 15 (9): 1370. doi:10.3390/life15091370
- 69. Sun MH, Wen ZY, Wang R, Gao C, Yin JL, Chang YJ. Parity and metabolic syndrome risk: a systematic review and meta-analysis of 15 observational studies with 62,095 women. Front Med. (2022) 9: 926944. doi:10.3389/fmed.2022.926944
- 70. Ye Q, Wang Z, Deng T, Lou Q, Wu H, Tang W. Association of socioeconomic status with metabolic syndrome and its components among adult population: a community-based cross-sectional study in Nanjing municipality of China. BMJ Open. (2023) 13 (10): e074059. doi:10.1136/bmjopen-2023-074059
- 71. Yaya S, Uthman OA, Ekholuenetale M, Bishwajit G. Socioeconomic inequalities in the risk factors of noncommunicable diseases among women of reproductive age in sub-saharan Africa: a multi-country analysis of survey data. Front Public Health. (2018) 6: 307. doi:10.3389/fpubh.2018.00307
- 72. National Strategic Plan for the Prevention and Control of Non-Communicable Diseases | 2021 – 2026 | WHO | Regional Office for Africa [Internet]. [cited 2026 Jul 2]. Available from:
- 73. Kenya Community Health Strategy 2020-2025 [Internet]. [cited 2026 Jul 2]. Available from:
- 74. Fisher Andrew A., John E. Laing, John E. Stoeckel, John Townsend. “ Handbook for family planning operations research design. ” (1991).
- 75. Espírito Santo LR, Faria TO, Silva CSO, Xavier LA, Reis VC, Mota GA. Socioeconomic status and education level are associated with dyslipidemia in adults not taking lipid-lowering medication: a population-based study. Int Health. (2022) 14 (4): 346 – 53. doi:10.1093/inthealth/ihz089
Citation
Mbae, U. K., et al. (2026). Sociodemographic determinants and prevalence of metabolic risk factors and the metabolic syndrome among women aged 20–49 in kirinyaga county, Kenya. Frontiers in Epidemiology, Volume 6. https://doi.org/
- Received
- Accepted
- Published
- Volume
- 6 - 2026
Copyright
© 2026 Mbae, Kyallo, Othoo, Ndungu, Kiage Mokua and Were.
License: https://creativecommons.org/licenses/by/4.0/
*Correspondence: Umotho Kinya Mbae
Article metrics
- Views
- 0
- Downloads
- 0
- Citations
- 0
- Shares
- 0
